TELADOC HEALTH, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $33.00K, a 3200.00% increase year-over-year.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $4.00K, a 99.53% decline year-over-year.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.00K, a 99.96% decline year-over-year.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $85.00K, a 97.62% decline from fiscal 2024.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $3.57M, a 140.78% increase from fiscal 2023.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $1.48M, a 74.83% decline from fiscal 2022.
- TELADOC HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $5.88M, a 77.18% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $33.00K 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $85.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $936.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.00K 10-Q · filed 2026-07-30 | $970.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $80.00K 10-Q · filed 2026-04-30 | $3.52M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $855.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.57M 10-K · filed 2026-02-26 |
| 2024-09-30 | $34.00K 10-Q · filed 2025-10-30 | $2.77M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.55M 10-Q · filed 2025-07-30 | $3.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $131.00K 10-Q · filed 2025-05-01 | $1.32M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.48M 10-K · filed 2026-02-26 |
| 2023-09-30 | $746.00K 10-Q · filed 2024-10-31 | $1.66M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $381.00K 10-Q · filed 2024-08-01 | $1.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $296.00K 10-Q · filed 2024-04-26 | $2.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.88M 10-K · filed 2025-02-27 |
| 2022-09-30 | $666.00K 10-Q · filed 2023-10-27 | $8.47M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $1.40M 10-Q · filed 2023-07-28 | $12.98M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $3.58M 10-Q · filed 2023-05-02 | $17.46M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $25.78M 10-K · filed 2024-02-23 |
| 2021-09-30 | $5.17M 10-Q · filed 2022-11-02 | $36.64M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $5.87M 10-Q · filed 2022-08-03 | $38.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $11.91M 10-Q · filed 2022-05-02 | $51.39M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $13.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $54.31M 10-K · filed 2023-03-01 |
| 2020-09-30 | $7.11M 10-Q · filed 2021-11-01 | |
| 2020-06-30 | $18.68M 10-Q · filed 2021-08-02 | |
| 2020-03-31 | $14.83M 10-Q · filed 2021-08-02 | |
| 2019-12-31 | $33.27M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $9.12M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $6.85M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $8.85M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $31.32M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $10.43M 10-Q · filed 2019-10-30 | $30.04M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $7.12M 10-Q · filed 2019-10-30 | $22.29M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $8.64M 10-Q · filed 2019-10-30 | $18.29M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $10.84M 10-K · filed 2020-02-26 |
| 2017-09-30 | $2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $7.31M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $6.25M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $1.20M 10-Q · filed 2017-05-08 | $3.22M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.52M 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $2.31M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $757.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $496.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $428.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | |
| 2014-12-31 | $747.00K 10-K · filed 2017-03-01 | |
| 2013-12-31 | $595.00K 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |